Abstract
Background: Rifaximin is an oral antimicrobial, which, until now, does not have standardized analytical methods in most official compendia. The literature shows few methods for the detection of drug, but has no analytical method for the determination of rifaximin in the pharmaceutical product. The lack of environmentally friendly methods with the use and minimal generation of toxic waste is also a gap.
Methods: This work proposed the development and validation of an infrared spectrophotometry method for the determination of rifaximin in tablets.
Results: The method was linear over the concentration range of 1.0-3.5 mg with correlation coefficient 0.9997 and the limits of detection and quantification of 0.20 and 0.61 mg, respectively.
Conclusion: The validated method was adequate, reliable, fast, economical and eco-friendly for the routine quality control of rifaximin in tablets. In the current fight against climate change, we can and must do our role , even if the role part is to develop and validate environmentally friendly method for routine use in the quality control of drugs and medicines in laboratories and pharmaceutical industries.
Keywords: Rifaximin, antimicrobial, infrared, environmentally friendly, method validation, tablets.
Graphical Abstract
Related Journals
Related Books
New Findings from Natural Substances
Pharmaceutical Chemistry and Production: An Introductory Textbook
Evidence-Based Research in Ayurveda against COVID-19 in Compliance with Standardized Protocols and Practices
Pharmaceuticals for Targeting Coronaviruses
Medical Applications of Beta-Glucan
Nanotechnology Driven Herbal Medicine for Burns: From Concept to Application
Postbiotics: Science, Technology and Applications
Biologically Active Natural Products from Asia and Africa: A Selection of Topics
28
2
1